Taylor Sandison

CIK 1702287 · Chief Medical Officer · last filed 2024-10-02

Taylor Sandison is a Chief Medical Officer who has filed 23 SEC Form 4 insider transactions across 1 company since 2017. The most recent filing, for CDTX, was dated Oct 2, 2024. Across all open-market trades the lifetime net is +$51.9K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

23

Lifetime Open-Market Net

$51.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Cidara Therapeutics, Inc. (CDTX) Delisted Chief Medical Officer 23,067 $221.38 $5.11M $51.9K 23 2024-10-02

Recent Filings

23 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-10-02 Cidara Therapeutics, Inc. (CDTX) Delisted Grant (A) $0 EDGAR
2024-09-13 Cidara Therapeutics, Inc. (CDTX) Delisted Sell (S) −924 -$10.8K EDGAR
2024-03-20 Cidara Therapeutics, Inc. (CDTX) Delisted Grant (A) +128,750 $0 EDGAR
2024-03-12 Cidara Therapeutics, Inc. (CDTX) Delisted Sell (S) −20,662 -$13.8K EDGAR
2023-09-13 Cidara Therapeutics, Inc. (CDTX) Delisted Sell (S) −18,793 -$17.8K EDGAR
2023-03-29 Cidara Therapeutics, Inc. (CDTX) Delisted Grant (A) +90,000 $0 EDGAR
2023-03-13 Cidara Therapeutics, Inc. (CDTX) Delisted Sell (S) −7,203 -$11.0K EDGAR
2022-09-13 Cidara Therapeutics, Inc. (CDTX) Delisted Sell (S) −18,478 -$12.7K EDGAR
2022-04-04 Cidara Therapeutics, Inc. (CDTX) Delisted Grant (A) +50,000 $0 EDGAR
2022-01-07 Cidara Therapeutics, Inc. (CDTX) Delisted Exer (M) +15,600 $0 EDGAR
Showing 110 of 23
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.